Literature DB >> 7980672

Systemic lupus erythematosus induced by ovulation induction treatment.

A Ben-Chetrit1, E Ben-Chetrit.   

Abstract

Infertile women are treated with various regimens for ovulation induction. The ultimate end-result of these treatments is a significant rise in levels of serum gonadotropins and estradiol--the most potent natural estrogen. Estrogens may affect diverse biologic functions, including immune and inflammatory reactions. A role for estrogens in the development or exacerbation of systemic lupus erythematosus (SLE) has been suggested by many studies. In this report, we present 3 cases of otherwise healthy women who received ovulation induction agents and subsequently developed full-blown SLE. The possible association between this treatment and SLE is discussed.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7980672     DOI: 10.1002/art.1780371109

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  4 in total

Review 1.  Review: Male systemic lupus erythematosus: a review of sex disparities in this disease.

Authors:  L-J Lu; D J Wallace; M L Ishimori; R H Scofield; M H Weisman
Journal:  Lupus       Date:  2009-11-27       Impact factor: 2.911

2.  Pregnancy-associated dermatomyositis.

Authors:  Mina Yassaee; Carrie L Kovarik; Victoria P Werth
Journal:  Arch Dermatol       Date:  2009-08

Review 3.  Human Chorionic Gonadotrophin: New Pleiotropic Functions for an "Old" Hormone During Pregnancy.

Authors:  Virginie Gridelet; Sophie Perrier d'Hauterive; Barbara Polese; Jean-Michel Foidart; Michelle Nisolle; Vincent Geenen
Journal:  Front Immunol       Date:  2020-03-13       Impact factor: 7.561

Review 4.  Systemic Lupus Erythematosus: Pathogenesis at the Functional Limit of Redox Homeostasis.

Authors:  Jay Pravda
Journal:  Oxid Med Cell Longev       Date:  2019-11-26       Impact factor: 6.543

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.